These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20540350

  • 1. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI, Lavrenova NIu, Goloborodova IV.
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [Abstract] [Full Text] [Related]

  • 2. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
    Lagarde M, Ghazi I, Dechavanne M.
    Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
    [Abstract] [Full Text] [Related]

  • 3. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM, Landgraf R, Loy A, Weber PC, Herberg LL.
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract] [Full Text] [Related]

  • 4. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP, Watts IS.
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [Abstract] [Full Text] [Related]

  • 5. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP, Sushkevich GN, Lukoianova TI.
    Patol Fiziol Eksp Ter; 1980 Apr; (4):80-5. PubMed ID: 6251418
    [No Abstract] [Full Text] [Related]

  • 6. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB, Dodge JA.
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [Abstract] [Full Text] [Related]

  • 7. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L, Marcinkiewicz E.
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract] [Full Text] [Related]

  • 8. Role of thromboxane A2.
    Ambler J, Birch J, Maguire ED, Wallis RB.
    Adv Exp Med Biol; 1985 Feb; 192():293-308. PubMed ID: 2939695
    [No Abstract] [Full Text] [Related]

  • 9. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM, Loy A, Christea C, Weber PC, Siess W, Herberg LL, Landgraf R.
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract] [Full Text] [Related]

  • 10. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W, Roth P, Weber PC.
    Thromb Haemost; 1981 Jun 30; 45(3):204-7. PubMed ID: 7025338
    [Abstract] [Full Text] [Related]

  • 11. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S, Maclouf J, Caen J, Bara L, Lecrubier C, Samama M.
    J Pharmacol; 1983 Jun 30; 14(2):141-50. PubMed ID: 6408316
    [Abstract] [Full Text] [Related]

  • 12. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA, Claesson HE, Kindahl H, Hammarström S.
    FEBS Lett; 1979 Feb 15; 98(2):247-50. PubMed ID: 217731
    [No Abstract] [Full Text] [Related]

  • 13. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
    Schrör K, Köhler P, Müller M, Peskar BA, Rösen P.
    Am J Physiol; 1981 Jul 15; 241(1):H18-25. PubMed ID: 6264810
    [Abstract] [Full Text] [Related]

  • 14. The platelet fibrinogen receptor.
    Peerschke EI.
    Semin Hematol; 1985 Oct 15; 22(4):241-59. PubMed ID: 2996149
    [No Abstract] [Full Text] [Related]

  • 15. Formation by phospholipase A2 of prostaglandins and endoperoxides in platelets of normal and essential fatty acid-deficient rats.
    Vincent JE, Zijlstra FJ.
    Adv Prostaglandin Thromboxane Res; 1978 Oct 15; 3():143-6. PubMed ID: 655005
    [No Abstract] [Full Text] [Related]

  • 16. Endogenous antiaggregatory prostaglandins can contribute to inhibition of hemostasis: a pharmacological study in vivo in humans.
    Gresele P, Arnout J, Deckmyn H, Vermylen J.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Oct 15; 17A():248-53. PubMed ID: 2821758
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandins, thromboxanes and platelets.
    Malmsten C.
    Br J Haematol; 1979 Apr 15; 41(4):453-8. PubMed ID: 219881
    [No Abstract] [Full Text] [Related]

  • 18. The role of prostaglandins in platelet function.
    Burch JW, Majerus PW.
    Semin Hematol; 1979 Jul 15; 16(3):196-207. PubMed ID: 113883
    [No Abstract] [Full Text] [Related]

  • 19. The effects of methyl mercury on platelets: induction of aggregation and release via activation of the prostaglandin synthesis pathway.
    Macfarlane DE.
    Mol Pharmacol; 1981 May 15; 19(3):470-6. PubMed ID: 7266471
    [No Abstract] [Full Text] [Related]

  • 20. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC, Martin TJ, Russell RG, Preston FE.
    Nature; 1977 Jun 30; 267(5614):850-2. PubMed ID: 197414
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.